Effects of chronic oral methylphenidate on cocaine self-administration and striatal dopamine D2 receptors in rodents
- PMID: 17599397
- DOI: 10.1016/j.pbb.2007.05.020
Effects of chronic oral methylphenidate on cocaine self-administration and striatal dopamine D2 receptors in rodents
Abstract
Background: Methylphenidate (MP) and amphetamine, which are the mainstay for the treatment of ADHD, have raised concerns because of their reinforcing effects and the fear that their chronic use during childhood or adolescence could induce changes in the brain that could facilitate drug abuse in adulthood.
Methods: Here we measured the effects of chronic treatment (8 months) with oral MP (1 or 2 mg/kg), which was initiated in periadolescent rats (postnatal day 30). Following this treatment, rats were tested on cocaine self-administration. In addition at 2 and 8 months of treatment we measured dopamine D2 receptor (D2R) availability in the striatum using [(11)C]raclopride microPET (microPET) imaging.
Results: Animals treated for 8 months with 2 mg/kg of MP showed significantly reduced rates of cocaine self-administration at adulthood than vehicle treated rats. D2R availability in the striatum was significantly lower in rats after 2 months of treatment with MP (1 and 2 mg/kg) but significantly higher after 8 months of MP treatment than in the vehicle treated rats. In vehicle treated rats D2R availability decreased with age whereas it increased in rats treated with MP. Because low D2R levels in the striatum are associated with a propensity for self-administration of drugs both in laboratory animals and in humans, this effect could underlie the lower rates of cocaine self-administration observed in the rats given 8 months of treatment with MP.
Conclusions: Eight month treatment with oral MP beginning in adolescence decreased cocaine-self administration (1 mg/kg) during adulthood which could reflect the increases in D2R availability observed at this life stage since D2R increases are associated with reduced propensity for cocaine self administration. In contrast, two month treatment with MP started also at adolescence decreased D2R availability, which could raise concern that at this life stage short treatments could possibly increase vulnerability to drug abuse during adulthood. These findings indicate that MP effects on D2R expression in the striatum are sensitive not only to length of treatment but also to the developmental stage at which treatment is given. Future studies evaluating the effects of different lengths of treatment on drug self-administration are required to assess optimal duration of treatment regimes to minimize adverse effects on the propensity for drug self administration.
Similar articles
-
Relationship between blockade of dopamine transporters by oral methylphenidate and the increases in extracellular dopamine: therapeutic implications.Synapse. 2002 Mar 1;43(3):181-7. doi: 10.1002/syn.10038. Synapse. 2002. PMID: 11793423
-
Chronic treatment with extended release methylphenidate does not alter dopamine systems or increase vulnerability for cocaine self-administration: a study in nonhuman primates.Neuropsychopharmacology. 2012 Nov;37(12):2555-65. doi: 10.1038/npp.2012.117. Epub 2012 Jul 18. Neuropsychopharmacology. 2012. PMID: 22805600 Free PMC article.
-
Enhanced reactivity and vulnerability to cocaine following methylphenidate treatment in adolescent rats.Neuropsychopharmacology. 2001 Nov;25(5):651-61. doi: 10.1016/S0893-133X(01)00281-0. Neuropsychopharmacology. 2001. PMID: 11682248
-
PET imaging of dopamine D2 receptors in monkey models of cocaine abuse: genetic predisposition versus environmental modulation.Am J Psychiatry. 2005 Aug;162(8):1473-82. doi: 10.1176/appi.ajp.162.8.1473. Am J Psychiatry. 2005. PMID: 16055768 Review.
-
Effects of stimulant drug use on the dopaminergic system: A systematic review and meta-analysis of in vivo neuroimaging studies.Eur Psychiatry. 2019 Jun;59:15-24. doi: 10.1016/j.eurpsy.2019.03.003. Epub 2019 Apr 11. Eur Psychiatry. 2019. PMID: 30981746
Cited by
-
Juvenile exposure to methylphenidate and guanfacine in rats: effects on early delay discounting and later cocaine-taking behavior.Psychopharmacology (Berl). 2019 Feb;236(2):685-698. doi: 10.1007/s00213-018-5096-0. Epub 2018 Nov 9. Psychopharmacology (Berl). 2019. PMID: 30411140
-
Vilazodone, a Selective Serotonin Reuptake Inhibitor with Diminished Impact on Methylphenidate-Induced Gene Regulation in the Striatum: Role of 5-HT1A Receptor.Mol Neurobiol. 2024 Apr;61(4):1907-1919. doi: 10.1007/s12035-023-03688-y. Epub 2023 Oct 9. Mol Neurobiol. 2024. PMID: 37807008 Free PMC article.
-
Sensitive periods of substance abuse: Early risk for the transition to dependence.Dev Cogn Neurosci. 2017 Jun;25:29-44. doi: 10.1016/j.dcn.2016.10.004. Epub 2016 Oct 29. Dev Cogn Neurosci. 2017. PMID: 27840157 Free PMC article. Review.
-
Chronic oral methylphenidate treatment reversibly increases striatal dopamine transporter and dopamine type 1 receptor binding in rats.J Neural Transm (Vienna). 2017 May;124(5):655-667. doi: 10.1007/s00702-017-1680-4. Epub 2017 Jan 23. J Neural Transm (Vienna). 2017. PMID: 28116523 Free PMC article.
-
Sex Differences in the Physiological and Behavioral Effects of Chronic Oral Methylphenidate Treatment in Rats.Front Behav Neurosci. 2017 Mar 28;11:53. doi: 10.3389/fnbeh.2017.00053. eCollection 2017. Front Behav Neurosci. 2017. PMID: 28400722 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical